Glaxo Smith Kline (BIOC.CA) Reports Year Ended 31/12/2020 Consolidated Results
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Currency : EGP
F/S Consolidated Period : From 01/01/2020 To 31/12/2020
Net Profit : 28,130,938
F/S Consolidated Period : From 01/01/2019 To 31/12/2019
Net Comparative Profit : 142,606,701
Audit Status : Audited
Source : Glaxo Smith Kline
ISIN Code : EGS38171C012
Currency : EGP
F/S Consolidated Period : From 01/01/2020 To 31/12/2020
Net Profit : 28,130,938
F/S Consolidated Period : From 01/01/2019 To 31/12/2019
Net Comparative Profit : 142,606,701
Audit Status : Audited
Source : Glaxo Smith Kline
Comments